Altis Biosystems

Altis Biosystems, Inc. has developed a patent-pending stem cell technology, recreating both the small and large human intestinal epithelium for drug screening and microbiome research for pharmaceutical and biotechnology companies. This is important because, until now, pharmaceutical companies only had the ability to use cancer cell lines and animal models before human testing. Altis' platform is high throughput, scalable, and reproducible. Altis provides a variety of services on its platform for customers, including toxicology, permeability, protein/gene expression, transport, etc. In addition, Altis is able to ship its platform to customers if they prefer to conduct testing in their own facilities.